Nurix Therapeutics, Inc.

NASDAQ:NRIX

19.2 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 109.99799.044116.7949.81354.62742.30458.95833.57164.47447.55641.53378.7880.506147.44188.207126.381119.356265.527159.32956.4134.816-39.039
Short Term Investments 499.586349.008326.349194.18233.281216.548222.219243.575244.667296.922255.746183.198215.214196.458197.814176.692161.79288.71614.17414.9372.90478.078
Cash and Short Term Investments 609.583448.052443.139243.993287.908258.852281.177277.146309.141344.478297.279261.978295.72343.898386.021303.073281.148354.243173.50371.34737.7239.039
Net Receivables 000002000008.2046.2045.2045.6793.98111.3463.85619.59000
Inventory 000000-1-1.2-1.1-1.1-0.700000000000
Other Current Assets 9.8047.9917.0786.9767.5957.0978.83711.1839.30810.3939.5110.3029.1949.3434.5813.7145.945.993.7115.3131.6340
Total Current Assets 619.387456.043450.217250.969295.503267.949290.014288.329318.449354.871306.789280.484311.118358.445396.281310.768298.434364.089196.80476.6639.35439.039
Non-Current Assets:
Property, Plant & Equipment, Net 45.89644.15247.39247.1747.9525.60828.43628.63429.50830.34930.92529.39425.3459.5698.3456.966.6726.5325.7893.9753.8710
Goodwill 0000000000000000000000
Intangible Assets 0000000000000000000000
Goodwill and Intangible Assets 00000000-3.301000-3.326000000000
Long Term Investments 0010.28111.1938.3229.88227.46348.44963.87969.12551.538123.685137.189121.48110.4477.19190.8940.8989.117.5840.5060
Tax Assets 00008.9410003.3010003.326000000000
Other Non-Current Assets 4.0613.4053.1413.3423.8234.7564.7114.7424.9234.9935.0584.157-0.2073.582.9151.7410.3470.3551.5740.570.317-39.039
Total Non-Current Assets 49.95657.55760.81461.70569.03640.24660.6181.82598.31104.46787.521157.236165.653134.629121.785.89297.90947.78516.47312.1294.694-39.039
Total Assets 669.343513.6511.031312.674364.539308.195350.624370.154416.759459.338394.31437.72476.771493.074517.981396.66396.343411.874213.27788.78944.0480
Liabilities & Equity:
Current Liabilities:
Account Payables 11.4823.9182.8135.9186.4012.1874.5255.6295.0646.0536.1426.0146.653.8615.4054.3883.4123.6114.9032.1271.5980
Short Term Debt 8.01413.10615.86814.6214.97810.72411.16611.11211.0610.99210.9410.867.694000000000
Tax Payables 1.2370.9060.710.4270.030.0340.0160.0890.0850.0410.0260.0530.0750.03700.3250.0740000.0330
Deferred Revenue 38.36447.99746.76946.07748.09832.03744.06338.30537.63336.34241.31943.18641.21235.2533.76132.75132.79930.29925.37209.6120
Other Current Liabilities 36.75720.36914.61920.58117.45116.51112.4929.74316.81314.07214.2385.93610.62711.5327.67810.5088.2547.1024.16127.9064.8940
Total Current Liabilities 95.85486.29680.77987.62386.95861.49372.26264.87870.65567.572.66566.04966.25850.6846.84447.97244.53941.01234.43630.03316.1370
Non-Current Liabilities:
Long Term Debt 20.28920.5941.7743.69246.255.2847.51610.21212.86815.4918.08620.65218.378000000000
Deferred Revenue Non-Current 26.20729.85838.67434.45745.02210.24314.68326.11835.97441.54845.86355.42859.02266.38172.12277.72360.68562.37471.387035.6930
Deferred Tax Liabilities Non-Current 00-38.67408.941-10.243-14.683-26.1183.301-41.548-45.863-55.4283.326000000000
Other Non-Current Liabilities 00-20.885-21.846-23.125-2.642-3.758-5.106-6.434-7.745-9.043-10.326-9.1890.7960.8370.8320.850.8680.871049.9320
Total Non-Current Liabilities 46.49650.44859.55956.30377.08812.88518.44131.22442.40849.29354.90665.75468.21167.17772.95978.55561.53563.24272.258085.6250
Total Liabilities 142.35136.744140.338143.926164.04674.37890.70396.102113.063116.793127.571131.803134.469117.857119.803126.527106.074104.254106.69430.033101.7620
Equity:
Preferred Stock 0000000000000000396.343411.874168.10948.19548.19548.195
Common Stock 0.0760.0670.0640.0490.0490.0490.0480.0470.0470.0470.0450.0450.0450.0450.0440.0390.0390.0390.0260.0110.0040
Retained Earnings -738.769-680.22-631.264-586.718-545.2-503.244-466.262-441.985-401.252-354.535-308.826-263.425-220.892-183.19-154.355-127.973-103.698-83.784-65.267-72.847-60.4560
Accumulated Other Comprehensive Income/Loss 0.150.344-0.135-0.35-0.655-1.228-1.903-3.247-4.319-3.742-3.085-2.066-0.608-0.0590.030.0490.0870.1380.1390.057-0.002-36.847
Other Total Stockholders Equity 1,265.5361,056.6651,002.028755.767746.299738.24728.038719.237709.22700.775578.605571.363563.757558.421552.459398.018393.841391.227171.72.977-48.1880
Total Shareholders Equity 526.993376.856370.693168.748200.493233.817259.921274.052303.696342.545266.739305.917342.302375.217398.178270.133290.269307.62106.583-21.607-57.71411.348
Total Equity 526.993376.856370.693168.748200.493233.817259.921274.052303.696342.545266.739305.917342.302375.217398.178270.133290.269307.62106.583-21.607-57.71411.348
Total Liabilities & Shareholders Equity 669.343513.6511.031312.674364.539308.195350.624370.154416.759459.338394.31437.72476.771493.074517.981396.66396.343411.874213.2778.42644.04811.348